Mayo Clinic (Arizona)

Sorting 3 by

Accepting patients

Phase 1/2 Multicenter, Open-Label Study of CTX-712 in Patients With Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
Learn more
  • CLK Inhibitor
  • Phase 1/2

Accepting patients

OPTIMIZE

A Phase II Study of Reduced Dose Post Transplantation Cyclophosphamide as GvHD Prophylaxis in Adult Patients With Hematologic Malignancies Receiving HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Learn more
  • Allogeneic Stem Cell Transplant
  • Phase 2

Accepting patients

Bone Marrow Failure Clinic Study

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
Learn more
  • Observational Trial